ホーム > 市場調査レポート > 医薬品

後発医薬品糖尿病バイオ医薬品

市場調査レポート

商品コード

1514966

短時間作用型インスリン市場：薬剤別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Short-Acting Insulin Market, By Drug, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日

カスタマイズ可能

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レポートハイライト

短時間作用型インスリン市場規模は2023年に75億2,420万米ドルとなり、2024年から2032年にかけてCAGR 4.50％で拡大

短時間作用型インスリン市場-市場力学

糖尿病蔓延防止に向けた政府の取り組みが市場成長を牽引

連邦、州、自治体レベルの政府政策は、ヘルスケアの質と安全性の向上に不可欠です。政策、制度、環境（PSE）の変化は、慢性疾患予防の長期戦略にとって重要な要素です。法規制や環境改変の目的は、健康的な行動をより利用しやすく、あるいは望ましいものにする一方で、有害な暴露をより困難に、あるいは違法なものにすることです。組織的介入は、機関や組織の運営や地域社会へのサービス提供を改善することに努める。糖尿病は3,000万人以上が罹患する慢性疾患です。2010年の医療費負担適正化法（ACA）は、政府、雇用主、個人の間で責任分担のパラダイムを確立し、すべての人が各地域で手頃な価格で質の高い医療保険に無制限に加入できるようにしました。

短時間作用型インスリン市場-主要インサイト

当社のリサーチアナリストは、世界市場は2024年から2032年にかけて約4.50%のCAGRで発展すると予測しています。

薬剤セグメンテーションに基づくと、2023年にはノボログ薬剤セグメントが世界のインスリン市場を独占します。

地域別では、北米が2023年に収益でリードしました。

短時間作用型インスリン市場-セグメンテーション分析：

短時間作用型インスリンの世界市場は、薬剤と地域に基づいてセグメント化されます。

市場は薬剤に基づいて3つのカテゴリーに分けられる：ノボログ、ヒューマログ、ヒュームリン。2023年にはノボログ薬剤セグメントが世界のインスリン市場を独占し、最大のCAGRが予測されます。ノボログは速効型インスリンで、食事時インスリンと同時に作用します。ノボログは、薬物動態学的および薬力学的に、糖尿病でない人のインスリンの生理的な食事時の反応により近い特徴を達成するために開発されました。

短時間作用型インスリン市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカに存在します。これらのゾーンは、どの国がビジネスをもたらすかに基づいてさらに分割されます。北米が市場を独占しています。世界で最も新興経済諸国であり、最大の経済規模を誇る北米は、世界トップクラスのヘルスケア施設を有しており、これが市場優位性の大きな基盤となっています。

アジア太平洋市場は、予測期間中、世界の短時間作用型インスリン市場で最も速い収益成長率を経験すると予測されています。アジア太平洋地域の成功は、この地域のヘルスケア産業が急速なペースで成長し、驚くほど拡大していることに起因しています。

短時間作用型インスリン市場-競合情勢：

競争の激しい短時間作用型インスリン市場では、複数の重要な製薬会社が速効型インスリン製品の開発とマーケティングに積極的に取り組んでいます。これらの企業は、製品の有効性、安全性、コスト、市場での存在感に基づいて競争しています。短時間作用型インスリン業界における重要な参加企業は、サノフィ、イーライリリー・アンド・カンパニー、ノボ・ノルディスクAS、ベリリー、センシールなどです。

イントロダクション
北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
アジア太平洋（APAC）
- 概要
- アジア太平洋地域の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
中東およびアフリカ
- 概要
- 中東・アフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他

第9章主要ベンダー分析：短時間作用型インスリン業界

競争ダッシュボード
企業プロファイル
- Novo Nordisk AS
- Sanofi
- Eli Lilly and Company
- Verily
- Sensile
- Others

第10章アナリストの全方位展望

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Short-Acting Insulin Market: Drug Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Drug
TABLE Global Short-Acting Insulin Market, by Drug 2019-2032 (USD Million)
TABLE TABLE TABLE Short-Acting Insulin Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Short-Acting Insulin Market, by Region 2019-2032 (USD Million)
TABLE North America Short-Acting Insulin Market, by Country, 2019-2032 (UD Million)
TABLE North America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
TABLE Europe Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
TABLE Europe Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
TABLE Asia Pacific Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
TABLE Latin America Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)
TABLE Middle East and Africa Short-Acting Insulin Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Short-Acting Insulin Market, by Drug, 2019-2032 (USD Million)

List of Figures

FIGURE Short-Acting Insulin Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Drug segment market share analysis, 2023 & 2032
FIGURE Drug segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Short-Acting Insulin Market share and leading players, 2023
FIGURE Europe Short-Acting Insulin Market share and leading players, 2023
FIGURE Asia Pacific Short-Acting Insulin Market share and leading players, 2023
FIGURE Latin America Short-Acting Insulin Market share and leading players, 2023
FIGURE Middle East and Africa Short-Acting Insulin Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Short-Acting Insulin Market share analysis by country, 2023
FIGURE Germany Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Short-Acting Insulin Market share analysis by country, 2023
FIGURE India Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philippines Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Short-Acting Insulin Market share analysis by country, 2023
FIGURE Brazil Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Short-Acting Insulin Market share analysis by country, 2023
FIGURE Saudi Arabia Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Short-Acting Insulin Market size, forecast and trend analysis, 2019 to 2032 (USD Million)

Product Code: ANV3095

REPORT HIGHLIGHT

Short-Acting Insulin Market size was valued at USD 7,524.2 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

The Short-Acting Insulin Market refers to the market segment dealing in insulin medications of a quick onset of action with a short, lengthier duration of effect. Short-acting insulin aims to provide glycemia control immediately post-meal to avoid glucose spikes due to food intake. Short-acting insulin is usually administered before or immediately after meals in order to closely mimic the body's natural supply of insulin to food intake. This is the very market of different pharmaceutical companies producing and distributing such medications to people with diabetes, so that these people may use them in a way of helping their body system regulate its blood sugar level effectively.

Short-Acting Insulin Market- Market Dynamics

Government's Initiatives to Prevent the Spread of Diabetes Drive Market Growth

Government policies at the federal, state, and municipal levels are critical to improving the quality and safety of healthcare. Changes in policy, systems, and the environment (PSE) are critical components of a long-term strategy to prevent chronic diseases. The goal of legislative regulations and environmental alterations is to make healthy behaviours more available or desirable while making detrimental exposures more difficult or illegal. Systemic interventions strive to improve an agency's or organization's operations and service delivery to the community. Diabetes is a chronic condition affecting over 30 million individuals. The Affordable Care Act of 2010 (ACA) established a shared responsibility paradigm among the government, employers, and individuals to ensure that everyone has unlimited access to affordable, high-quality health insurance in their local regions.

Short-Acting Insulin Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 4.50% from 2024 to 2032.

Based on Drug segmentation, the Novolog drugs segment will dominate the worldwide insulin market in 2023.

On the basis of region, North America was the leading revenue generator in 2023

Short-Acting Insulin Market- Segmentation Analysis:

The Global Short-Acting Insulin Market is segmented on the basis of Drug and Region.

The market is divided into three categories based on drugs: Novolog, Humalog, and Humulin. The Novolog drugs segment will dominate the worldwide insulin market in 2023, with the greatest CAGR projected. Novolog is a rapid-acting insulin that works in tandem with mealtime insulin. It was developed largely to attain pharmacokinetic as well as pharmacodynamic features that are more closely related to the physiological mealtime response of insulin in a person without diabetes.

Short-Acting Insulin Market- Geographical Insights

Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. North America dominates the market. North America, the world's most developed and largest economy, has world-class healthcare facilities, which is the major basis for its market dominance.

The Asia-Pacific market is predicted to experience the quickest revenue growth rate in the worldwide Short-Acting Insulin market during the forecast period; the Asia-Pacific region's success can be attributed to the amazing expansion of the region's healthcare industry, which has grown at a rapid pace.

Short-Acting Insulin Market- Competitive Landscape:

In the competitive Short-Acting Insulin Market, several important pharmaceutical companies are actively involved in the development and marketing of rapid-acting insulin products. These businesses compete based on product efficacy, safety, cost, and market presence. Some significant participants in the short-acting insulin industry are Sanofi, Eli Lilly & Company, Novo Nordisk AS, Verily, and Sensile.

Recent Developments:

In June 2021, Eli Lilly and Company announced a $400 million investment to expand its production capacity.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL SHORT-ACTING INSULIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Novo Nordisk AS

Sanofi

Eli Lilly and Company

Verily

Sensile

Others

GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032

Novolog
Humalog
Humulin

GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Short-Acting Insulin Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Short-Acting Insulin Market Snippet by Drug
- 2.1.2. Short-Acting Insulin Market Snippet by Country
- 2.1.3. Short-Acting Insulin Market Snippet by Region
2.2. Competitive Insights

3. Short-Acting Insulin Key Market Trends

3.1. Short-Acting Insulin Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Short-Acting Insulin Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Short-Acting Insulin Market Opportunities
3.4. Short-Acting Insulin Market Future Trends

4. Short-Acting Insulin Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Short-Acting Insulin Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Short-Acting Insulin Market Landscape

6.1. Short-Acting Insulin Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Short-Acting Insulin Market - By Drug

7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug, 2023 & 2032 (%)
- 7.1.2. Novolog
- 7.1.3. Humalog
- 7.1.4. Humulin

8. Short-Acting Insulin Market- By Geography

8.1. Introduction
- 8.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
8.2. North America
- 8.2.1. Overview
- 8.2.2. Short-Acting Insulin Key Manufacturers in North America
- 8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.2.4. North America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.2.5. U.S.
  - 8.2.5.1. Overview
  - 8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.2.5.3. U.S. Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.2.6. Canada
  - 8.2.6.1. Overview
  - 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.2.6.3. Canada Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3. Europe
- 8.3.1. Overview
- 8.3.2. Short-Acting Insulin Key Manufacturers in Europe
- 8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.3.4. Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.5. Germany
  - 8.3.5.1. Overview
  - 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.5.3. Germany Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.6. Italy
  - 8.3.6.1. Overview
  - 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.6.3. Italy Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.7. United Kingdom
  - 8.3.7.1. Overview
  - 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.7.3. United Kingdom Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.8. France
  - 8.3.8.1. Overview
  - 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.8.3. France Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.9. Russia
  - 8.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.9.2. Russia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.10. Netherlands
  - 8.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.10.2. Netherlands Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.11. Sweden
  - 8.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.11.2. Sweden Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.12. Poland
  - 8.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.12.2. Poland Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.3.13. Rest of Europe
  - 8.3.13.1. Overview
  - 8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.3.13.3. Rest of the Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4. Asia Pacific (APAC)
- 8.4.1. Overview
- 8.4.2. Short-Acting Insulin Key Manufacturers in Asia Pacific
- 8.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.4.4. Asia Pacific Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.5. India
  - 8.4.5.1. Overview
  - 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.5.3. India Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.6. China
  - 8.4.6.1. Overview
  - 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.6.3. China Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.7. Japan
  - 8.4.7.1. Overview
  - 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.7.3. Japan Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.8. South Korea
  - 8.4.8.1. Overview
  - 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.8.3. South Korea Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.9. Australia
  - 8.4.9.1. Overview
  - 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.9.3. Australia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.10. Thailand
  - 8.4.10.1. Overview
  - 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.10.3. Thailand Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.11. Indonesia
  - 8.4.11.1. Overview
  - 8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.11.3. Indonesia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.12. Philippines
  - 8.4.12.1. Overview
  - 8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.12.3. Philippines Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.4.13. Rest of APAC
  - 8.4.13.1. Overview
  - 8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.4.13.3. Rest of APAC Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.5. Latin America
- 8.5.1. Overview
- 8.5.2. Short-Acting Insulin Key Manufacturers in Latin America
- 8.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.5.4. Latin America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.5. Brazil
  - 8.5.5.1. Overview
  - 8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.5.3. Brazil Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.6. Mexico
  - 8.5.6.1. Overview
  - 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.6.3. Mexico Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.7. Argentina
  - 8.5.7.1. Overview
  - 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.7.3. Argentina Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.8. Colombia
  - 8.5.8.1. Overview
  - 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.8.3. Colombia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.5.9. Rest of LATAM
  - 8.5.9.1. Overview
  - 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.5.9.3. Rest of LATAM Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6. Middle East and Africa
- 8.6.1. Overview
- 8.6.2. Short-Acting Insulin Key Manufacturers in Middle East and Africa
- 8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 8.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.5. Saudi Arabia
  - 8.6.5.1. Overview
  - 8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.5.3. Saudi Arabia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.6. United Arab Emirates
  - 8.6.6.1. Overview
  - 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.6.3. United Arab Emirates Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.7. Israel
  - 8.6.7.1. Overview
  - 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.7.3. Israel Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.8. Turkey
  - 8.6.8.1. Overview
  - 8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.8.3. Turkey Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.9. Algeria
  - 8.6.9.1. Overview
  - 8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.9.3. Algeria Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.10. Egypt
  - 8.6.10.1. Overview
  - 8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.10.3. Egypt Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
- 8.6.11. Rest of MEA
  - 8.6.11.1. Overview
  - 8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 8.6.11.3. Rest of MEA Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)

9. Key Vendor Analysis- Short-Acting Insulin Industry

9.1. Competitive Dashboard
9.2. Company Profiles
- 9.2.1. Novo Nordisk AS
- 9.2.2. Sanofi
- 9.2.3. Eli Lilly and Company
- 9.2.4. Verily
- 9.2.5. Sensile
- 9.2.6. Others

10. 360 Degree Analyst View

11. Appendix

11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us

短時間作用型インスリン市場：薬剤別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Short-Acting Insulin Market, By Drug, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

全表示

レポートハイライト

短時間作用型インスリン市場-セグメンテーション分析：

短時間作用型インスリン市場-競合情勢：

目次

第1章短時間作用型インスリン市場概要

第2章エグゼクティブサマリー

第3章短時間作用型インスリンの主要市場動向

第4章短時間作用型インスリン産業研究

第5章短時間作用型インスリン市場：COVID-19の影響分析

第6章短時間作用型インスリン市場情勢

第7章短時間作用型インスリン市場：薬剤別

第8章短時間作用型インスリン市場：地域別

第9章主要ベンダー分析：短時間作用型インスリン業界

第10章アナリストの全方位展望

List of Tables

List of Figures

REPORT HIGHLIGHT

Short-Acting Insulin Market- Segmentation Analysis:

Short-Acting Insulin Market- Competitive Landscape:

Recent Developments:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032

GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Short-Acting Insulin Market Overview

2. Executive Summary

3. Short-Acting Insulin Key Market Trends

4. Short-Acting Insulin Industry Study

5. Short-Acting Insulin Market: COVID-19 Impact Analysis

6. Short-Acting Insulin Market Landscape

7. Short-Acting Insulin Market - By Drug

8. Short-Acting Insulin Market- By Geography

9. Key Vendor Analysis- Short-Acting Insulin Industry

10. 360 Degree Analyst View

11. Appendix

短時間作用型インスリン市場：薬剤別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Short-Acting Insulin Market, By Drug, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

全表示

レポートハイライト

短時間作用型インスリン市場-セグメンテーション分析：

短時間作用型インスリン市場-競合情勢：

目次

第1章 短時間作用型インスリン市場概要

第2章 エグゼクティブサマリー

第3章 短時間作用型インスリンの主要市場動向

第4章 短時間作用型インスリン産業研究

第5章 短時間作用型インスリン市場：COVID-19の影響分析

第6章 短時間作用型インスリン市場情勢

第7章 短時間作用型インスリン市場：薬剤別

第8章 短時間作用型インスリン市場：地域別

第9章 主要ベンダー分析：短時間作用型インスリン業界

第10章 アナリストの全方位展望

List of Tables

List of Figures

REPORT HIGHLIGHT

Short-Acting Insulin Market- Segmentation Analysis:

Short-Acting Insulin Market- Competitive Landscape:

Recent Developments:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032

GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Short-Acting Insulin Market Overview

2. Executive Summary

3. Short-Acting Insulin Key Market Trends

4. Short-Acting Insulin Industry Study

5. Short-Acting Insulin Market: COVID-19 Impact Analysis

6. Short-Acting Insulin Market Landscape

7. Short-Acting Insulin Market - By Drug

8. Short-Acting Insulin Market- By Geography

9. Key Vendor Analysis- Short-Acting Insulin Industry

10. 360 Degree Analyst View

11. Appendix

第1章短時間作用型インスリン市場概要

第2章エグゼクティブサマリー

第3章短時間作用型インスリンの主要市場動向

第4章短時間作用型インスリン産業研究

第5章短時間作用型インスリン市場：COVID-19の影響分析

第6章短時間作用型インスリン市場情勢

第7章短時間作用型インスリン市場：薬剤別

第8章短時間作用型インスリン市場：地域別

第9章主要ベンダー分析：短時間作用型インスリン業界

第10章アナリストの全方位展望